Showing 2,221 - 2,240 results of 106,501 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 0.98s Refine Results
  1. 2221
  2. 2222
  3. 2223
  4. 2224
  5. 2225
  6. 2226
  7. 2227

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…To mitigate the systemic adverse effects of tofacitinib, 5-ASA–PABA–MAC and 5-ASA–PABA–diamine colon-specific delivery systems were constructed, and tofacitinib azo prodrugs <b>9</b> and <b>20a–20g</b> were synthesized accordingly. …”
  8. 2228

    Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase by Karin Simonin-Le Jeune (464354)

    Published 2013
    “…Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. …”
  9. 2229

    Decreased copper content and activity/expression of SOD1 in circulating erythrocytes from <i>ms/−</i> mice. by Małgorzata Lenartowicz (150659)

    Published 2014
    “…<p>(<b>A</b>) Decreased copper content in erythrocytes of <i>ms/−</i> mice. …”
  10. 2230
  11. 2231
  12. 2232
  13. 2233
  14. 2234

    Targeting <i>A20</i> decreases glioma stem cell survival. by Anita B. Hjelmeland (104655)

    Published 2010
    “…<p>(A) Annexin V staining demonstrates increased apoptosis with <i>A20</i> targeting in glioma stem cells isolated from a D317 glioma xenograft or a T3359 patient specimen passaged short term in immunocompromised mice. …”
  15. 2235
  16. 2236
  17. 2237
  18. 2238
  19. 2239

    Minimal underlying data set. by Machiko K. Asaka (18334223)

    Published 2024
    “…This investigation involved measurement using the Mullen Scale of Early Learning in a representative sample of Japanese infants followed up from the age of 0 to 2 years (Nishimura et al., 2016). …”
  20. 2240

    Data_Sheet_1_Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection.doc by Yanhua Wu (141984)

    Published 2023
    “…The change of both absolute and relative risks for hospitalization was more evident (RR = 0.47, 95%CI: 0.42–0.53;RD% =10.61, 95%CI: 8.64–12.59) and a significant increase was observed for the absolute differences in death in the elderly (RD% = 5.60, 95CI%: 4.65–6.55); the change of the absolute differences in the risk of hospitalization and death were most markedly observed in the patients with booster vaccination (RD%<sub>hospitalization</sub> = 8.60, 95CI%: 5.95–11.24; RD%<sub>death</sub> = 3.70, 95CI%: 0.34–7.06).…”